About the Authors
- Eliyahu V. Khankin
-
Contributed equally to this work with: Eliyahu V. Khankin, Walter P. Mutter
Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
- Walter P. Mutter
-
Contributed equally to this work with: Eliyahu V. Khankin, Walter P. Mutter
Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
- Hector Tamez
-
Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
- Hai-Tao Yuan
-
Affiliation Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
- S. Ananth Karumanchi
-
* E-mail: sananth@bidmc.harvard.edu
Affiliations Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America, Howard Hughes Medical Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America
- Ravi Thadhani
-
Affiliation Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America
Competing Interests
Authors Eli Khankin, Walter Mutter, S. Ananth Karumanchi and Ravi Thadhani are listed as co-inventors on provisional patents filed by the Harvard Hospitals that is related to use of soluble epo receptor for the diagnosis and therapy of anemia.
Author Contributions
Conceived and designed the experiments: EK WM SAK RT. Performed the experiments: EK WM. Analyzed the data: EK WM HT HTY SAK RT. Contributed reagents/materials/analysis tools: RT. Wrote the paper: EK WM SAK RT.